Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV(1)

BACKGROUND: The primary lung function endpoint in clinical trials in adolescent and adult patients with asthma is usually forced expiratory volume in one second (FEV(1)). The objective of our analysis was to assess whether peak expiratory flow (PEF) is a suitable alternative primary lung function en...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpin, David M. G., Meltzer, Eli O., Pisternick-Ruf, Wendelgard, Moroni-Zentgraf, Petra, Engel, Michael, Zaremba-Pechmann, Liliana, Casale, Thomas, FitzGerald, J. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637596/
https://www.ncbi.nlm.nih.gov/pubmed/31319851
http://dx.doi.org/10.1186/s12931-019-1119-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637596/
https://www.ncbi.nlm.nih.gov/pubmed/31319851
http://dx.doi.org/10.1186/s12931-019-1119-6

Ejemplares similares